A presentation to the 2016 ISMTE US Conference. Something of a “state of our industry” overview, or perhaps, everything I needed to know I learned from the other bloggers at The Scholarly Kitchen.
The University of Florida and Elsevier have entered into a partnership to build links between the institutional repository and ScienceDirect, which has received quite a bit of criticism in recent weeks.I have found it useful to try to understand the different sides of what seems to me to be a debate about how best to utilize the increasingly mature infrastructure and programmatic capacity for scholarly communications.
With no clear benefits to researchers, a frustrating user experience, and no penalties for non-compliance, ClinicalTrials.gov is becoming increasingly irrelevant to clinical researchers and the world at large with each passing day. What does this mean for public access to research results? Is an obligation to patients putting themselves at risk in trials being breached? Why has it failed to live up to its potential?
On the three year anniversary of the OSTP Public Access memo, AIP’s Fred Dylla takes a look at the significant progress made.
A new survey highlights the lack of awareness among researchers for funding agency public access policies.
The administrative burden stemming from funding agency and institutional access policies is just beginning. Can we reduce the severity of this storm with careful planning and collaboration?